Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1165 Eastlake Ave E, Seattle, Washington
State of incorporation
Washington
Fiscal year end
December 31
Former names
Adaptive TCR Corp (to 6/2/2011)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 472 % -5.18%
Quick Ratio 18.4 % +8.55%
Debt-to-equity 106 % +39.1%
Return On Equity -64.2 % -55.7%
Return On Assets -31.1 % -33.1%
Operating Margin -125 % -18.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 147M shares +2.12%
Common Stock, Shares, Outstanding 147M shares +2.14%
Entity Public Float 756M USD -15.9%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 146M shares +1.59%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +1.59%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 175M USD -5.33%
Research and Development Expense 120M USD -12.3%
Selling and Marketing Expense 88.6M USD -3.52%
General and Administrative Expense 82.7M USD -2.95%
Costs and Expenses 393M USD +3.82%
Operating Income (Loss) -219M USD -12.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -225M USD -12.4%
Net Income (Loss) Attributable to Parent -215M USD -10.2%
Earnings Per Share, Basic -1.49 USD/shares -9.56%
Earnings Per Share, Diluted -1.49 USD/shares -9.56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71.2M USD -24.7%
Accounts Receivable, after Allowance for Credit Loss, Current 42M USD +35.7%
Inventory, Net 13.3M USD -33.1%
Assets, Current 374M USD -25.4%
Property, Plant and Equipment, Net 65.3M USD -19.7%
Operating Lease, Right-of-Use Asset 51M USD -35.4%
Goodwill 119M USD 0%
Other Assets, Noncurrent 3.39M USD +55.4%
Assets 620M USD -21.6%
Accounts Payable, Current 12.2M USD +92.2%
Employee-related Liabilities, Current 6.4M USD +4.64%
Accrued Liabilities, Current 7.91M USD -1.58%
Contract with Customer, Liability, Current 46.9M USD -22.3%
Liabilities, Current 83M USD -7.93%
Contract with Customer, Liability, Noncurrent 44.2M USD -18.1%
Operating Lease, Liability, Noncurrent 86.9M USD -9.94%
Liabilities 346M USD -5.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax -106K USD +94.4%
Retained Earnings (Accumulated Deficit) -1.19B USD -22%
Stockholders' Equity Attributable to Parent 275M USD -35.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 275M USD -35.2%
Liabilities and Equity 620M USD -21.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.4M USD +35.2%
Net Cash Provided by (Used in) Financing Activities 44K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 44.5M USD -29.3%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 147M shares +2.14%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.2M USD +37.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.29M USD -17.1%
Deferred Tax Assets, Valuation Allowance 402M USD +16.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 417M USD +12.2%
Operating Lease, Liability 96.5M USD -8.78%
Depreciation 4.79M USD -4.26%
Payments to Acquire Property, Plant, and Equipment 1.51M USD -48.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -213M USD -10.9%
Lessee, Operating Lease, Liability, to be Paid 118M USD -10.6%
Property, Plant and Equipment, Gross 141M USD +2.66%
Operating Lease, Liability, Current 9.59M USD +3.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.1M USD +2.97%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 21.4M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.9M USD -3.13%
Deferred Tax Assets, Operating Loss Carryforwards 252M USD +19.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.3M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.3M USD +2.83%
Operating Lease, Payments 3.7M USD +8.82%
Additional Paid in Capital 1.47B USD +4.57%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD +0.24%
Deferred Tax Assets, Net of Valuation Allowance 14.5M USD -41.9%
Share-based Payment Arrangement, Expense 62.5M USD +9.16%
Interest Expense 13.3M USD -15.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%